Over the weekend, Google announced a shift in its rules for subscription news websites.
Such sites no longer must provide users three free articles a day or face less prominence in search results, following complaints from media giants like News Corp over sales.
Google, which is the largest part of parent company Alphabet, said previously that free samples would lead to increased subscriptions
Alphabet (NASDAQ:GOOGL) saw shares close on Friday 0.92% higher at US$973.72.
It comes as its US subsidiary has now submitted an application to the all-powerful FDA to market schizophrenia treatment RBP-7000.
The application includes the results of its Phase 3 study. The firm also revealed it had struck an agreement with Durect Corp (NASDAQ:DRRX) to buy a number of patents to bolster its IP position.
Meanwhile, looking ahead to earnings on Monday and egg producer Cal-Maine Foods Inc (NASDAQ:CALM) is reporting and Wall Street forecasts the group to post a quarterly loss of US$0.23 per share on revenues of US$275.97mln.
Shares closed on Friday 0.98% higher at US$41.10.